Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $779.2500 (-0.21%) ($778.1700 - $779.2500) on Wed. Jun. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.52% (three month average) | RSI | 76 | Latest Price | $779.2500(-0.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.7% a day on average for past five trading days. | Weekly Trend | REGN advances 2.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(48%) XLV(44%) DIA(31%) VYM(30%) XLF(29%) | Factors Impacting REGN price | REGN will decline at least -0.76% in a week (0% probabilities). VXX(-24%) VIXM(-20%) EDOC(-6%) ACES(-5%) TBT(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.76% (StdDev 1.52%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $778.64(0.08%) | 10 Day Moving Average | $764.02(1.99%) | 20 Day Moving Average | $751.11(3.75%) | To recent high | -6.2% | To recent low | 7.5% | Market Cap | $82.623b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |